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It is more than 15 years since the intellectual disabilities 
specialty was mired in controversy when data from 
California were reported,1,2 which suggested higher 
rates of mortality among people with intellectual 
disabilities living in the community compared with 
those living in institutions. At the time, this ﬁ nding was 
regarded as an attack on the movement of people with 
intellectual disabilities into the community, and there 
were criticisms of research quality3 and eﬀ orts to refute 
the ﬁ ndings.4 Over time, the ﬁ ndings stood5 and the 
methods used in studies to refute them were themselves 
challenged.6 Subsequently, people started asking 
important questions about the role of community-
based primary care and community hospital care 
in supporting the lives of people with intellectual 
disabilities living in the community. 
In The Lancet, Pauline Heslop and colleagues7 report 
the results of the Conﬁ dential Inquiry into premature 
deaths of people with intellectual disabilities in the UK. 
Rather than being a criticism of community placements, 
it draws attention to serious questions remaining long 
after the California study and, in a diﬀ erent national 
context, about the quality of health care being oﬀ ered to 
people with intellectual disabilities in local communities, 
this time as compared with the general population.
The Conﬁ dential Inquiry reviewed all deaths of people 
with intellectual disabilities who had been registered 
with a general practitioner in southwest England, and 
who died between June, 2010, and May, 2012. Deaths 
were described as avoidable, amenable (ie, could 
have been avoided in principle by medical knowledge 
and health care available at the time of death), or 
premature. Contributory factors were grouped into 
four domains: intrinsic to the individual, within the 
family and environment, care provision, and service 
provision. The deaths of a comparator group of people 
without intellectual disabilities but much the same in 
age, sex, and cause of death, and registered at the same 
general practices as those with intellectual disabilities, 
were also investigated.
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The main question now is whether the trial by Kahn 
and colleagues1 has given us a deﬁ nitive answer on the 
usefulness of ECS for the prevention of PTS. Although 
this is the largest and only placebo controlled study so 
far, some questions remain. What are the individual 
contributions of the placebo eﬀ ect, suboptimum 
compliance, and patient characteristics to the lack of 
eﬀ ectiveness? A multicentre randomised trial comparing 
usual care (ECS for 2 years) with individualised care 
based on Villalta scores is in progress (ClinicalTrials.gov, 
NCT01429714). This future study will hopefully give 
additional information on some open questions: is there 
any beneﬁ t of treatment with ECS, which patients beneﬁ t 
most, and what is the optimum treatment duration?
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Methodology is important; in this report7 the authors 
note that there was not a comprehensive register 
of people with intellectual disabilities to draw from. 
The lines between the general population and people 
with mild intellectual disabilities were blurred, and the 
comparator sample was not matched with the group of 
people with intellectual disabilities on socioeconomic 
status, as noted by the authors, or on any kind of 
baseline comorbidity index.8 The samples involved were 
small and comparisons were associational rather than 
causal. It is of concern that our consideration of issues 
crucial to the lives of people with intellectual disabilities 
continues to be limited by methodological issues raised 
for decades; additional systematic and longitudinal 
work is needed9 and must be supported by steps to 
ensure access to high-quality data.
247 individuals with intellectual disabilities died 
during the study period; their median age was 64 years 
(IQR 52–75). Male individuals with intellectual disabilities 
died on average 13 years earlier than the population 
of England and Wales (median age at death 65 years 
[IQR 52–75] vs 78 years), and female individuals died on 
average 20 years earlier (63 years [54–75] vs 83 years). 
Avoidable deaths from causes amenable to change 
by good quality health care were more than twice as 
common in people with intellectual disabilities (37%, 
90 of 244) than in the general population of England 
and Wales (13%). The ﬁ ndings of the Conﬁ dential 
Inquiry are not an aberration; premature death is well 
established.10 Other ﬁ ndings were that better quality 
health care would have reduced this elevated mortality. 
This latter ﬁ nding is of particular importance because, 
rather than simply raising a concern, it oﬀ ers insight into 
next steps for exploring what must change if diﬀ erent 
outcomes are to be achieved in the future. 
These ﬁ ndings beg the question of why such shortfalls 
in care are occurring. There are longstanding ﬁ ndings 
of higher levels of chronic disorders in people with 
intellectual disability, and in particular increased mental 
health concerns.11 Also, data from the Intellectual 
Disability Supplement to the Irish Longitudinal 
Study on Ageing12 have shown diﬀ erent patterns in 
multimorbidity, with eye disease and mental health 
problems most often associated with a second disorder, 
and mental health and neurological disease as the most 
prevalent multimorbidity pairing. In the Conﬁ dential 
Inquiry report7 such diﬀ erences were further borne out 
in ﬁ ndings of unaddressed or poorly addressed higher 
rates of nervous and congenital causes of death among 
people with intellectual disability. Those involved in 
community-based health care are probably neither 
aware of nor considering these health presentation 
diﬀ erences for people with intellectual disabilities in the 
planning and implementation of health-care delivery. 
The ﬁ ndings of the Conﬁ dential Inquiry report not only 
raise concerns about individual care, but also question 
and challenge the organisation and responsiveness of 
health care when people with intellectual disabilities 
enter clinics, practices, and hospitals.
There are educational challenges to be addressed for 
health-care practitioners. Additionally, providers of 
services for people with intellectual disabilities must 
examine how they can be more eﬀ ective adjuncts and 
advocates working within community-based health care 
to minimise negative outcomes.
Finally, there is more to be known. Still to be 
established are eﬀ ects from lower levels of unhealthy 
lifestyle choices, higher levels but diﬀ erent patterns of 
chronic disorders, diﬀ erential access and diﬀ erential 
outcomes from health-care responses, and pre-existing 
lifelong disabilities and their roles as predictors and 
mediators of premature death. Such studies will require 
the ability to track incidence and prevalence of chronic 
conditions and related deaths. The need to improve the 
available data remains.
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In the ﬁ rst few months of 2014, the UK media have 
already provided saturation coverage to mark a century 
since the outbreak of the First World War. Education 
Secretary for England Michael Gove had described it as 
a “just war”; others have recalled the words of the late 
Harry Patch, the last surviving veteran of the conﬂ ict, 
who called it “legalised mass murder”. There has been 
controversy over the necessity of the war itself, and of 
the form that commemoration should take. What can a 
medical journal add to this? 
During the conﬂ ict, The Lancet published papers on 
the diverse medical challenges of warfare—from surgery 
to psychiatry. This year, we would like to remember the 
war—and those who lost their lives, soldiers and civilians 
alike—by considering how it shaped and deﬁ ned the 
challenges to human health of today’s world. Massive 
social convulsions such as the First World War force 
both citizens and their leaders to face issues that would 
otherwise have been ignored or unaddressed. The role of 
the state in providing public health and health care; the 
rights of those with disabilities; the toll of mechanised 
warfare; the health impact of population movement: 
these are just some of the facets of human health 
that we will explore in a special issue later this year. 
We invite submissions of relevant original research or 
review articles. Please submit your work via our online 
submission system, stating in your cover letter that the 
submission is in response to this call for papers. The 
deadline for submissions is June 30, 2014.
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